中化生 (1762)
中化生 is a TWSE-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$69.11M, up 90.5% from a year earlier. EPS over the last four quarters totals -NT$0.92.
Company profile
Data as of 2026-10-18
- Market
- TWSE-listed
- Industry
- Biotech & Medical Care
- Listed
- 2010-12-20
- Founded
- 1964-05-19
- Paid-in capital
- NT$769.18M
- Common shares issued
- 76,918,000
- Legal name
- 中化合成生技股份有限公司
- Website
- https://www.ccsb.com.tw
Monthly revenue
Data as of 2026-10-17
| Month | Revenue | MoM | YoY |
|---|---|---|---|
| 2026-09 | NT$69.11M | +17.0% | +90.5% |
| 2026-08 | NT$59.09M | -34.2% | +30.3% |
Year to date: +27.9% vs. last year (Jan–Sep 2026)
Earnings per share (EPS)
Data as of 2026-06-30
| Quarter | EPS (NT$) |
|---|---|
| 2026 Q2 | 0.75 |
| 2026 Q1 | 1.64 |
| 2025 Q4 | -2.55 |
| 2025 Q3 | -0.76 |
| 2025 Q2 | -1.21 |
| 2025 Q1 | 0.13 |
| 2024 Q4 | 0.26 |
| 2024 Q3 | -0.10 |
Last four quarters: -NT$0.92
Dividends
Data as of 2026-10-18
| Period | Cash (NT$) | Stock (NT$) | Ex-dividend | Ex-rights | Paid |
|---|---|---|---|---|---|
| 2025 年度 | 0.00 | 0.00 | — | — | — |
Shareholder structure
Data as of 2026-10-16
| Holding range | Holders | Share of total |
|---|---|---|
| 1–999 shares | 47,379 | 1.6% |
| 1,000–5,000 shares | 5,169 | 13.3% |
| 5,001–10,000 shares | 656 | 6.7% |
| 10,001–15,000 shares | 196 | 3.3% |
| 15,001–20,000 shares | 122 | 2.9% |
| 20,001–30,000 shares | 111 | 3.7% |
| 30,001–40,000 shares | 51 | 2.4% |
| 40,001–50,000 shares | 43 | 2.6% |
| 50,001–100,000 shares | 73 | 6.9% |
| 100,001–200,000 shares | 33 | 5.9% |
| 200,001–400,000 shares | 12 | 4.5% |
| 400,001–600,000 shares | 4 | 2.7% |
| 600,001–800,000 shares | 4 | 3.8% |
| 800,001–1,000,000 shares | 3 | 3.5% |
| 1,000,001+ shares | 5 | 36.1% |
TDCC data for 2026-10-16: 5 holders own more than 1,000 lots (36.1% of shares), and 47,379 hold less than one lot (1.6%).
Institutional net buying (last 20 trading days)
Data as of 2026-10-19
| Date | Foreign | Trust | Dealers | Total |
|---|---|---|---|---|
| 2026-10-19 | 6 | 0 | -2 | 4 |
| 2026-10-16 | 30 | 0 | 0 | 30 |
| 2026-10-15 | 36 | 0 | 0 | 36 |
| 2026-10-14 | 7 | 0 | 2 | 9 |
| 2026-10-13 | -17 | 0 | -1 | -18 |
| 2026-10-12 | -59 | 0 | 0 | -59 |
| 2026-10-08 | 118 | 0 | -2 | 116 |
| 2026-10-07 | 4 | 0 | -4 | 0 |
| 2026-10-06 | -11 | 0 | 0 | -11 |
| 2026-10-05 | 2 | 0 | 0 | 2 |
| 2026-10-02 | -8 | 0 | 0 | -8 |
| 2026-10-01 | -9 | 0 | 0 | -9 |
| 2026-09-30 | 12 | 0 | 1 | 13 |
| 2026-09-29 | -18 | 0 | 4 | -14 |
| 2026-09-24 | -3 | 0 | 0 | -3 |
| 2026-09-23 | 0 | 0 | 0 | 0 |
| 2026-09-22 | 8 | 0 | 0 | 8 |
| 2026-09-21 | 4 | 0 | 0 | 4 |
| 2026-09-18 | 21 | 0 | 5 | 26 |
| 2026-09-17 | 22 | 0 | 1 | 23 |
Unit: lots (1,000 shares). Over the last 20 trading days, institutions were net buyers of 149 lots.
Price (official close)
Data as of 2026-10-19
Last close NT$34.35 (2026-10-19); 52-week range NT$24.20–44.75.
Sources
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Market Observation Post System (MOPS)
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Depository & Clearing Corporation public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
Charts, drawing tools, and the P/E calculator are in the app, free to use.